6533b7cefe1ef96bd12571b3
RESEARCH PRODUCT
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
Hitoshi TakizawaM. John HicksCarl E. AllenCarl E. AllenHarshal AbhyankarHarshal AbhyankarJuliana IdoyagaStephen J. SimkoStephen J. SimkoAlbert RuzoPhilip J. LupoPhilip J. LupoMiriam MeradBjörn E. ClausenAlbert ShihMarie-luise BerresTricia L. PetersRikhia ChakrabortyRikhia ChakrabortyKenneth HeymHélène SalmonSergio A. LiraMatthew CollinMarylene LeboeufMarkus G. ManzKenneth L. McclainKenneth L. McclainMonique BeltrãoKaren Phaik Har LimVenetia BigleyJeremy Pricesubject
MalePathologyendocrine system diseasesCellular differentiationCD34Antigens CD34Mice0302 clinical medicineLangerhans cell histiocytosisBone MarrowRisk FactorsImmunology and Allergyskin and connective tissue diseasesChild0303 health sciencesCell Differentiation3. Good healthHistiocytosismedicine.anatomical_structurePhenotypeTreatment Outcome030220 oncology & carcinogenesisChild PreschoolAntigens Surface2723 Immunology and AllergyFemaleProto-Oncogene Proteins B-rafmedicine.medical_specialtyImmunologyCD11c610 Medicine & healthBiologyArticle03 medical and health sciencesGermline mutationmedicineAnimalsHumansCell LineageGenetic Predisposition to DiseaseLectins C-TypeProgenitor cellneoplasms030304 developmental biology2403 ImmunologyHistocompatibility Antigens Class II302InfantCorrectionDendritic Cellsmedicine.diseaseHematopoietic Stem Cellsdigestive system diseasesCD11c Antigenenzymes and coenzymes (carbohydrates)Histiocytosis Langerhans-CellMannose-Binding Lectins10032 Clinic for Oncology and HematologyMutationBone marrowdescription
BRAF-V600E expression is identified in hematopoietic progenitor and precursor myeloid dendritic cells in patients with high-risk LCH, and enforced expression of BRAF-V600E in CD11c+ cells recapitulates a high-risk LCH-like phenotype in mice.
year | journal | country | edition | language |
---|---|---|---|---|
2014-01-01 | The Journal of experimental medicine |